News
Digital techniques could 'turbocharge' R&D after COVID-19, say UK chemistry leaders
The UK’s Royal Society of Chemistry has called for digital techniques …
21558 items found
Views & Analysis
Expanding research capacity into neglected tropical diseases
Professor Paul Kaye from the University of York, whose research team …
News
AI startup Nucleai has immuno-oncology treatment failures in its sights
Israeli company Nucleai is putting artificial intelligence to work to …
Views & Analysis
Applying digital health to systemic healthcare challenges
The de-prioritisation of face-to-face interactions between patients …
News
EU regulators approve AstraZeneca's Lynparza in pancreatic cancer
The European Commission has approved AstraZeneca and MSD’s Lynparza …
News
US snaps up first supplies of Regeneron’s COVID-19 antibody
Hard on the heels of Regeneron moving its COVID-19 antibody cocktail …
News
Kiadis Pharma and Sanofi to unlock power of natural killer cells in multiple myeloma
Sanofi has struck an exclusive rights deal with Dutch biotech Kiadis …
Events
Partner Content
Applied Biocatalysis Summit 2020
Advancing Sustainable, Streamlined API and Chemical Production using …
Digital
Marketing for life science companies - drivers of change
Healthcare’s digital revolution has been transformed into a digital …
Partner Content
Partner Content
ProQR Therapeutics presenting keynote at Oligonucleotide Therapeutics and Delivery
SMi reports: SMi are pleased to inform you that Vera Brinks, Director …
Partner Content
Partner Content
News
GSK and Sanofi close in on £500m COVID-19 vaccine deal with UK - report
GlaxoSmithKline and Sanofi are close to agreeing a £500m deal to …
News
Camino and Jazz take top honours at rebranded PMi Awards 202...
The PMi Awards 2025 – formerly known as the PM Society Digital Awards – celebrated its inaugural edition under its new name at The Brewery in London on 11th September.
Digital
Sponsored
Tracking studies get smarter: AI meets human intelligence
Having a continuous pulse on brand health is essential for pharmaceutical companies to inform strategic decisions and establish Key Performance Indicators (KPIs) in an ever-changing market
Market Access
12 questions with: Daniel Kohlstaedt
Daniel Kohlstaedt, managing director of PurpleLeaf Strategy, with more than 18 years of experience in pharma, talks about his journey through the industry.
R&D
Life Sciences Industry Report - Biologics and Generics
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Oncology
Doing good in people’s lives: Amy Burroughs discusses CML
Amy Burroughs, CEO, Terns Pharmaceuticals, discusses available treatments for CML, the potential of allosteric TKIs, and the wider oncology landscape.
Oncology
Life Sciences Industry Report - Oncology
Developments in the oncology space in 2024 brought hope to both industry and patients.
R&D
Partner Content
4th LNP Immunogenicity & Toxicity Summit
Assessing LNP Immunogenicity & Toxicity to Effectively Monitor Clinical Safety & Ensure Regulatory Compliance for Novel Therapeutics & Vaccines
R&D
Partner Content
7th Gene Therapy Analytical Development Summit | Leading AD ...
Advancing Analytics & QC from Pre-IND to BLA
